FormWeb • sulfamethoxazole-trimethoprim

Oregon Department of Corrections

Approved Formulary

Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions

Webpage Links

Add Formweb to your mobile device

Android iOS

February P&T meeting minutes have been posted.

Oregon Department of Corrections

Approved Formulary

Search results for:

sulfamethoxazole-trimethoprim

sulfamethoxazole-trimethoprim

Formulary Duration Restrictions Limited to 6 weeks without TLC approval. Exception: HIV patients do not need approval for durations exceeding 6 weeks.
Cell Status Approved

Brand names: Bactrim DS, Cotrim DS, Septra DS, Sulfamethoxazole-Trimethoprim DS

Form	Strength
TABLET, ORAL	800 mg-160 mg

Last updated: Aug. 23, 2021

UpToDate
Micromedex
Pharmacist's Letter
FDA DailyMed Package Insert
WebMD Pill Identifier

This site is intended for the staff of Oregon Department of Corrections.
While others may view accessible pages, Oregon Department of Corrections makes no warranty, express or implied,
as to the use of this information outside of Oregon Department of Corrections.